Cumulus Neuroscience, a global digital health company, recently shared their findings at the AAIC 2023 Annual Meeting and Technology and Dementia Preconference.
The interim analysis of their groundbreaking CNS-101 study revealed that individuals with mild Alzheimer's dementia are not only capable but also willing to participate in intensive home-based functional neurophysiology studies.
The presentation took place at the Alzheimer's Association International Conference 2023 held in Amsterdam, Netherlands. Cumulus utilized their innovative Cumulus Neuroassessment Platform to collect data through repeated at-home sampling. This real-world feasibility study is conducted in collaboration with the University of Cambridge and Trinity Biomedical Science Institute.